SuperworthJaguar Health market cap JAGX
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $702.9K
- Highest close in our data
- $121.7M
- Jan 2021
Jaguar Health is worth $702.9K at the close on Oct 23, 2026, at $2.04 a share.
That is down 85% over the last year and down 98% over five years.
Its highest close in our data was $121.7M in Jan 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $702.9K | $552.5K | $5.3M | −83% |
| 2025 | $4.1M | $1.3M | $13.6M | −66% |
| 2024 | $12.2M | $1M | $29.5M | +374% |
| 2023 | $2.6M | $568K | $6.9M | −39% |
| 2022 | $4.2M | $4.2M | $16.2M | −75% |
| 2021 | $16.7M | $16.7M | $121.7M | −33% |
| 2020 | $24.8M | $5.3M | $24.8M | +118% |
| 2019 | $11.4M | $782.1K | $22.3M | +124% |
| 2018 | $5.1M | $3.7M | $15M | +20% |
| 2017 | $4.2M | $2.2M | $10.3M | +44% |
| 2016 | $2.9M | $2.7M | $8.4M | −52% |
| 2015 | $6.1M | $5.1M | $14.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Jaguar Health's size, closest first, today.
| Company | Market cap |
|---|---|
| JAGXJaguar Health | $702.9K |
| LABTLakewood-Amedex Biotherapeutics | $734.6K |
| NXTSNexentis Technologies | $761.8K |
| DCOYDecoy Therapeutics | $635.5K |
| VBIOValion Bio | $834.3K |
| SBFMSunshine Biopharma | $581.6K |
| ARTLArtelo Biosciences | $1.3M |
| LNAILunai Bioworks | $1.5M |
| GNPXGenprex | $1.5M |
| GOVXGeoVax Labs | $1.5M |
| ONCOOnconetix | $1.7M |
| Peer median | $1.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Jaguar Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.